Department of Medical Microbiology & Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Global Health, School of Public Health, Boston University, Boston, MA, USA.
Nat Rev Microbiol. 2023 Dec;21(12):805-817. doi: 10.1038/s41579-023-00945-8. Epub 2023 Aug 2.
Seasonal influenza viruses cause recurring global epidemics by continually evolving to escape host immunity. The viral constraints and host immune responses that limit and drive the evolution of these viruses are increasingly well understood. However, it remains unclear how most of these advances improve the capacity to reduce the impact of seasonal influenza viruses on human health. In this Review, we synthesize recent progress made in understanding the interplay between the evolution of immunity induced by previous infections or vaccination and the evolution of seasonal influenza viruses driven by the heterogeneous accumulation of antibody-mediated immunity in humans. We discuss the functional constraints that limit the evolution of the viruses, the within-host evolutionary processes that drive the emergence of new virus variants, as well as current and prospective options for influenza virus control, including the viral and immunological barriers that must be overcome to improve the effectiveness of vaccines and antiviral drugs.
季节性流感病毒通过不断进化以逃避宿主免疫来引起全球周期性流行。病毒的限制和宿主免疫反应限制并推动了这些病毒的进化,这方面的理解日益深入。然而,目前尚不清楚这些进展中有多少可以提高降低季节性流感病毒对人类健康影响的能力。在这篇综述中,我们综合了近期在理解先前感染或接种疫苗所诱导的免疫进化与人类抗体介导免疫的异质积累驱动的季节性流感病毒进化之间相互作用方面的进展。我们讨论了限制病毒进化的功能限制、驱动新病毒变体出现的宿主内进化过程,以及当前和未来的流感病毒控制选择,包括为提高疫苗和抗病毒药物的有效性必须克服的病毒和免疫障碍。